Latest News about MOLN
Recent news which mentions MOLN
21 Stocks Moving in Tuesday's Pre-Market Session
January 11, 2022
From Benzinga
60 Biggest Movers From Yesterday
January 11, 2022
From Benzinga
Why Molecular Partners Stock Crushed the Market Today
January 10, 2022
From Motley Fool
Mid-Day Market Update: Nasdaq Dips 300 Points; Apria Shares Surge
January 10, 2022
From Benzinga
45 Stocks Moving In Monday's Mid-Day Session
January 10, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 10, 2022
From Benzinga
From InvestorPlace
Here’s the market move Cathie Wood says is ‘ridiculous’ as her flagship fund sputters
January 10, 2022
From MarketWatch
20 Stocks Moving in Monday's Pre-Market Session
January 10, 2022
From Benzinga
Novartis To In-License COVID-19 Treatment From Molecular Partners, After Encouraging Mid-Stage Data
January 10, 2022
From Benzinga
From MarketWatch
12 Health Care Stocks Moving In Thursday's Intraday Session
December 30, 2021
From Benzinga
50 Biggest Movers From Yesterday
December 15, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 14, 2021
From Benzinga
34 Stocks Moving In Tuesday's Mid-Day Session
December 14, 2021
From Benzinga
Molecular Partners Inks License Deal With Novartis For $580M
December 14, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 14, 2021
From Benzinga
The Daily Biotech Pulse: Mesoblast, Novartis Sever COVID-19 Treatment Partnerships, Sigilon To Reduce Workforce, ASH Presentations Move Stocks
December 14, 2021
From Benzinga
From InvestorPlace
20 Stocks Moving in Tuesday's Pre-Market Session
December 14, 2021
From Benzinga
Molecular Partners' Ensovibep Shows Early Safety Profile In COVID-19
December 06, 2021
Tickers
MOLN
From Benzinga
52 Biggest Movers From Yesterday
December 01, 2021
From Benzinga
These 2 Nasdaq Biotechs Are Bucking the Market Downtrend
November 30, 2021
From Motley Fool
35 Stocks Moving In Tuesday's Mid-Day Session
November 30, 2021
From Benzinga
The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout
November 30, 2021
From Benzinga
From InvestorPlace
Molecular Partners Says Its COVID-19 Antiviral Still Effective Against Positions Mutated In Omicron
November 30, 2021
From Benzinga
20 Stocks Moving In Tuesday's Pre-Market Session
November 30, 2021
From Benzinga
61 Biggest Movers From Yesterday
November 23, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.